Think Research Corp (TSXV:THNK)
C$ 0.315 0 (0%) Market Cap: 24.82 Mil Enterprise Value: 71.97 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

Think Research Corporation at GCFF Global Chinese Financial Conference -- Healthcare Investment North America (Virtual) Transcript

Jun 16, 2022 / 03:25PM GMT
Release Date Price: C$0.52 (-8.77%)
Sachin Aggarwal
Think Research Corporation - CEO

Thanks, Gilbert. And thanks for having us, everyone. Thanks for joining us this morning. My name is Sachin Aggarwal, the CEO of Think Research.

And what we do, we are a software company. And what we do is we get new clinical evidence and new clinical knowledge into the hands of doctors, nurses, and pharmacists through enterprise relationships. So these are relationships with -- these are licenses with clinics, with hospitals, with entire government. We then deploy our solutions to those doctors, nurses, and pharmacists so they can practice up-to-date medicine.

As Gilbert said, our mission is to organize the world's health knowledge so everyone gets the best care, okay? So essentially, new evidence, new knowledge to the bedside so patients get better care. What we do -- what we are to our clients is an essential data service for the clinicians.

Gilbert mentioned a few of our stats. We are on track for a run rate of approximately CAD91 million by the end of fiscal 2022. And just again, more than 300,000 clinicians -- that's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot